Nancy Simonian
2022
In 2022, Nancy Simonian earned a total compensation of $3.5M as President & Chief Executive Officer at Syros Pharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $316,800 |
|---|---|
| Option Awards | $974,802 |
| Salary | $636,615 |
| Stock Awards | $1,557,683 |
| Other | $1,980 |
| Total | $3,487,880 |
Simonian received $1.6M in stock awards, accounting for 45% of the total pay in 2022.
Simonian also received $316.8K in non-equity incentive plan, $974.8K in option awards, $636.6K in salary and $2K in other compensation.
Rankings
In 2022, Nancy Simonian's compensation ranked 1,030th out of 5,760 executives tracked by ExecPay. In other words, Simonian earned more than 82.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,030 out of 5,760 | 82nd |
Division Manufacturing | 483 out of 3,136 | 85th |
Major group Chemicals And Allied Products | 174 out of 1,422 | 88th |
Industry group Drugs | 157 out of 1,323 | 88th |
Industry Pharmaceutical Preparations | 116 out of 969 | 88th |
Source: SEC filing on April 21, 2023.
Simonian's colleagues
We found two more compensation records of executives who worked with Nancy Simonian at Syros Pharmaceuticals in 2022.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019